Shijiazhuang Yiling Pharmaceutical Co. Ltd
Shijiazhuang Yiling Pharmaceutical Co. Ltd
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Effect of XY0206 on the QTc Interval in Chinese Healthy Participants | Acute Myeloid Leukemia With FLT3/ITD Mutation | Recruiting | Phase 1 | 2025-09-09 | NCT07162116 | |
| A Study of XY0206 Versus Salvage Chemotherapy In Patients With Relapsed or Refractory AML With FLT3-ITD-Mutation (ALIVE) | Acute Myeloid Leukemia With FLT3/ITD Mutation | Not yet recruiting | Phase 3 | 2023-05-26 | NCT05876832 |